Kala Pharmaceuticals announces positive results from Phase 3 trial of KPI-121 in cataract surgery
1 April 2015 | By Victoria White
Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery...